Ignite Creation Date:
2025-12-18 @ 9:27 AM
Ignite Modification Date:
2025-12-23 @ 9:56 PM
Study NCT ID:
NCT04073147
Status:
None
Last Update Posted:
2022-01-19 00:00:00
First Post:
2019-08-26 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma
Sponsor:
Organization:
Raw JSON
{}